Effect of early and current Helicobacter pylori infection on the risk of anaemia in 6.5-year-old Ethiopian children

listen audio

Study Justification:
This study aimed to investigate the association between Helicobacter pylori (H. pylori) infection and the risk of anemia in 6.5-year-old Ethiopian children. Previous studies conducted in high-income countries have suggested a link between H. pylori infection and anemia, but evidence from low-income countries is lacking. This study aimed to fill this gap in knowledge by examining the relationship between H. pylori infection in early childhood and anemia at the age of 6.5 years in an Ethiopian birth cohort.
Study Highlights:
– The study included 856 children from a population-based birth cohort in Ethiopia.
– An interviewer-led questionnaire was administered to collect information on demographic and lifestyle variables.
– Haemoglobin levels and red cell indices were measured using an automated haematological analyzer.
– Stool samples were analyzed for H. pylori antigen.
– The study found that any H. pylori infection up to age 6.5 years was significantly associated with an increased risk of anemia at age 6.5.
– Children with H. pylori infection also showed a significant reduction in haemoglobin concentration and red cell indices.
Study Recommendations:
Based on the findings of this study, the following recommendations can be made:
1. Public health interventions should be implemented to reduce the prevalence of H. pylori infection in children.
2. Screening and treatment programs for H. pylori infection should be considered as a preventive measure for anemia in children.
3. Further research is needed to explore the underlying mechanisms through which H. pylori infection leads to anemia.
Key Role Players:
To address the recommendations, the following key role players are needed:
1. Public health authorities: Responsible for implementing interventions and programs to reduce H. pylori infection.
2. Healthcare providers: Involved in screening and treating H. pylori infection in children.
3. Researchers: Conduct further studies to understand the mechanisms of H. pylori-induced anemia and evaluate the effectiveness of interventions.
Cost Items for Planning Recommendations:
While the actual cost of implementing the recommendations will vary depending on the context, some key cost items to consider in planning include:
1. Diagnostic tests: Costs associated with screening and diagnosing H. pylori infection.
2. Treatment: Costs of medications and healthcare services for treating H. pylori infection.
3. Public health interventions: Costs of implementing interventions to reduce H. pylori infection, such as health education campaigns and sanitation improvements.
4. Research funding: Costs of conducting further research to explore mechanisms and evaluate interventions.
Please note that the above cost items are provided as examples and may not reflect the actual costs in a specific setting.

The strength of evidence for this abstract is 7 out of 10.
The evidence in the abstract is moderately strong, but there are some areas for improvement. The study design is a birth cohort study, which is generally considered to be a strong design for establishing causality. The study also includes a large sample size (856 children) and uses multiple logistic and linear regression to analyze the data. However, the abstract does not provide information on potential confounders that were controlled for in the analysis, which could affect the validity of the results. Additionally, the abstract does not mention any limitations of the study, such as potential biases or sources of error. To improve the evidence, the abstract should provide more details on the confounders controlled for and any limitations of the study.

Background: Epidemiological and clinical studies in high income countries have suggested that Helicobacter pylori (H. pylori) may cause anaemia, but evidence is lacking from low income countries. We examined associations between H. pylori infection in early childhood and anaemia at the age of 6.5 years in an Ethiopian birth cohort. Methods: In 2011/12, 856 children (85.1 % of the 1006 original singletons in a population-based birth cohort) were followed up at age six and half. An interviewer-led questionnaire administered to mothers provided information on demographic and lifestyle variables. Haemoglobin level and red cell indices were examined using an automated haematological analyzer (Cell Dyn 1800, Abbott, USA), and stool samples analyzed for H. pylori antigen. The independent effects of H. pylori infection (measured at age 3.5 and 6.5 years) on anaemia, haemoglobin level, and red cell indices (measured at age 6.5 years) were determined using multiple logistic and linear regression. Results: The prevalence of anemia was 34.8 % (257/739), and the mean (SD) haemoglobin concentration was 11.8 (1.1) gm/dl. Current H. pylori infection at age 6.5 years was positively, though not significantly related to prevalence of anaemia (adjusted OR, 95 % CI, 1.15; 0.69, 1.93, p = 0.59). Any H. pylori infection up to age 6.5 years was significantly associated with an increased risk of anaemia at age 6.5 (adjusted OR, 95 % CI, 1.68; 1.22, 2.32, p = 0.01). A significant reduction in haemoglobin concentration and red cell indices was also observed among children who had any H. pylori infection up to age 6.5 (Hb adjusted β = -0.19, 95 % CI, -0.35 to -0.03, p = 0.01; MCV adjusted β = -2.22, 95 % CI, -3.43 to -1.01, p = 0.01; MCH adjusted β = -0.63, 95 % CI, -1.15 to – 0.12, p = 0.01; and MCHC adjusted β = -0.67, 95 % CI, -1.21 to -0.14, p = 0.01), respectively. Conclusion: This study provides further evidence from a low income country that any H. pylori infection up to age 6.5 is associated with higher prevalence of anaemia, and reduction of haemoglobin level and red cell indices at age 6.5.

A detailed description of the original Butajira birth cohort study has been published [27, 30]. Briefly, the birth cohort is nested in the Butajira Demographic Surveillance Site (DSS) which covers a sample of nine rural and one urban administrative units in and around the town of Butajira in Southern Ethiopia [31]. Between July 2005 and February 2006, all women in the DSS aged 15–49 and in their third trimester of pregnancy were identified by the DSS fieldworkers and invited to participate in the study. Of the 1,234 eligible women, 1,065 were recruited (86 % of those eligible) and all live singleton babies born to these women (n = 1006) were followed-up as a birth cohort. After informed consent forms were signed by the mothers, information on demographic and selected lifestyle factors was collected by interviewer-led administered questionnaire during pregnancy: information on mother’s age, place of residence, ethnicity, religion, occupation, education and household income was collected. At birth and during the follow-up visits, the project data collectors visited the child at home and collected information on potential confounders such as birth weight, history of vaccination, household size, vitamin A supplementation, intestinal parasitosis, anthropometric characteristics and sanitary conditions. At follow up visits at ages 3, 5 and 6.5 years, mothers were also asked to collect a faecal sample from their child using a leak-proof plastic container. The samples were then transported for analysis in the Butajira health center laboratory to ascertain the child’s H. pylori and intestinal parasites infection status. Furthermore, at the 6.5 year follow up visit, a blood sample was collected from each child using a vacutainer tube, and transported to Butajira hospital for haematological analysis. H. pylori status was evaluated using the commercially available SD Bioline H. pylori stool antigen test (Standard Diagnostics, Inc) according to the manufacturer’s instructions. A portion of faeces (about 50 mg) from a stool sample was swirled with assay diluent solution at least for ten times, until the sample has been dissolved, and then allowed to settle for 5 min at room temperature. About 100 μL of the prepared sample was placed on the H. pylori Ag examination device. The test results were checked about 15 min later. One red line indicated negative and a double red line indicated an H. pylori positive result. Additionally, all faecal samples were examined qualitatively using the modified formol-ether concentration method to ascertain the child’s intestinal parasites infection status. At the 6.5-year follow-up, a two ml whole blood sample was collected into Ethylene diaminetetraacetic acid (EDTA) tubes between 8:00 and 10:00 am and analyzed on the same day using an automated haematological analyzer (Cell Dyn 1800, Abbott, USA) at Butajira hospital. The analyzer aspirates the blood sample, dilutes and counts leukocytes, erythrocytes and thrombocytes, measures Mean Cell Volume (MCV) and Haemoglobin (Hb), and calculates Haematocrit, Mean Cell Haemoglobin (MCH), and Mean Cell Haemoglobin Concentration (MCHC). This instrument was monitored daily with normal, high and low controls provided by the manufacturer before running the specimen to ensure quality of haematological analyses. The primary study outcome was anaemia at age 6.5, and was defined according to the WHO hemoglobin cutoff: < 11.5 g/dL for children 5–11 years [32]. Data were double-entered into EpiData 3.1 (EpiData, Denmark). The datasets were cleaned, coded and merged ready for analysis using Stata 12 (Statacorp, College Station, Texas, USA). Prior to investigating the association between H. pylori infection and anaemia, univariate analyses were used to identify the possible confounders. Variables that were associated with both exposure and outcome variables in the crude analysis using statistical significance at p value  10 % or if they were independently associated with the outcome at p < 0.10. Probability values < 0.05 were considered statistically significant for main effects. Sensitivity analysis was done to compare the distribution of demographic and life style variables between study subject who have complete outcome data (i.e. “complete-case”) and "all respondents" populations. The study was approved by the Institutional Review Board (IRB) of Addis Ababa University, College of Health Sciences, Ethiopia. Written, informed consent was obtained from the mothers after they have been clearly informed about the study, and in keeping with the requirements of the College of Health Sciences IRB all women and their children were reimbursed for health care costs. Children were also requested to give assent and were informed of their right to refuse to participate in the study and to withdraw at any time during the study without jeopardizing their right of access to other health services. Invasive procedures such as collection of blood samples were fully explained to parents and children, and were carried out using sterile disposable materials.

Based on the information provided, it seems that the study is focused on investigating the association between Helicobacter pylori (H. pylori) infection and anaemia in Ethiopian children. The study collected data on H. pylori infection status, haemoglobin levels, and red cell indices in children at different ages. The findings suggest that H. pylori infection up to the age of 6.5 years is associated with a higher prevalence of anaemia and a reduction in haemoglobin levels and red cell indices at age 6.5.

In terms of potential innovations to improve access to maternal health, it is important to note that the study primarily focuses on the association between H. pylori infection and anaemia in children, rather than directly addressing maternal health. However, based on the broader context of maternal health and the potential impact of anaemia on maternal health, here are some innovations that could be considered:

1. Integrated screening and treatment programs: Implementing integrated screening programs that include testing for H. pylori infection and anaemia during antenatal care visits can help identify and address these conditions early on. This can improve maternal health outcomes by ensuring timely diagnosis and treatment.

2. Health education and awareness campaigns: Conducting targeted health education and awareness campaigns to educate pregnant women and their families about the importance of nutrition, including iron-rich foods, and the potential risks of H. pylori infection and anaemia during pregnancy. This can empower women to make informed decisions about their health and seek appropriate care.

3. Improved access to diagnostic tools: Ensuring that healthcare facilities have access to reliable and affordable diagnostic tools for detecting H. pylori infection and anaemia. This can help facilitate early diagnosis and appropriate treatment, leading to better maternal health outcomes.

4. Collaboration between different healthcare providers: Promoting collaboration between obstetricians, gynecologists, general practitioners, and other healthcare providers to ensure comprehensive and coordinated care for pregnant women. This can help address multiple health issues, including H. pylori infection and anaemia, in a holistic manner.

5. Research and evidence generation: Encouraging further research to better understand the relationship between H. pylori infection, anaemia, and maternal health outcomes. This can help inform the development of targeted interventions and policies to improve maternal health.

It is important to note that these recommendations are based on the broader context of maternal health and the potential impact of anaemia on maternal health. Further research and consultation with healthcare professionals would be needed to tailor these recommendations to specific settings and populations.
AI Innovations Description
Based on the provided description, the recommendation to improve access to maternal health would be to conduct further research on the association between Helicobacter pylori (H. pylori) infection and anaemia in low-income countries. This research should focus on understanding the mechanisms through which H. pylori infection leads to anaemia and explore potential interventions to prevent or treat anaemia in children. Additionally, efforts should be made to raise awareness among healthcare providers and communities about the link between H. pylori infection and anaemia, and the importance of early detection and treatment. This can be done through educational campaigns and training programs for healthcare professionals. Furthermore, policies and guidelines should be developed to ensure that pregnant women and children have access to appropriate diagnostic tests and treatment for H. pylori infection. This may involve integrating H. pylori testing and treatment into existing maternal and child health programs. Overall, a comprehensive approach that combines research, awareness-raising, and policy interventions is needed to improve access to maternal health and address the impact of H. pylori infection on anaemia.
AI Innovations Methodology
Based on the provided information, it seems that the request is to consider innovations that can improve access to maternal health and to describe a methodology to simulate the impact of these recommendations on improving access to maternal health. However, the provided text is a detailed description of a study on the effect of Helicobacter pylori infection on the risk of anemia in Ethiopian children. It does not directly address innovations for improving access to maternal health or describe a methodology for simulating the impact of these innovations.

To provide relevant recommendations and a methodology for simulating their impact on improving access to maternal health, please provide more specific information or clarify your request.

Share this:
Facebook
Twitter
LinkedIn
WhatsApp
Email